Table 2.
CD3+CD62L+ (%) | CD3+CD62L− (%) | |||||
---|---|---|---|---|---|---|
Healthy subjects (n = 7) | Sarcoidosis (n = 20) | IPF (n = 10) | Healthy subjects (n = 7) | Sarcoidosis (n = 20) | IPF (n = 10) | |
Peripheral blood | 39·5 | 13·1* | 15·8 | 28·1 | 41·5 | 36·0 |
(29·8–44·8) | (4·4–26·6) | (8·3–41·4) | (21·2–29·1) | (24·0–60·9) | (17·4–56·1) | |
BALF | 5·2 | 3·6 | 5·1 | 76·5 | 86·2**† | 83·7 |
(2·9–7·4) | (1·4–13·2) | (1·2–8·9) | (75·0–79·4) | (61·5–94·3) | (72·1–88·5) |
Values are expressed as median (range).
IPF, Idiopathic pulmonary fibrosis.
P < 0·01 compared with healthy subjects;
P < 0·05 compared with healthy subjects.
P < 0·01 compared with IPF.